Nicol Macpherson

3.4k total citations · 2 hit papers
25 papers, 2.5k citations indexed

About

Nicol Macpherson is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Nicol Macpherson has authored 25 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Nicol Macpherson's work include Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (4 papers) and Cancer Treatment and Pharmacology (3 papers). Nicol Macpherson is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Viral-associated cancers and disorders (4 papers) and Cancer Treatment and Pharmacology (3 papers). Nicol Macpherson collaborates with scholars based in Canada, United States and Australia. Nicol Macpherson's co-authors include Randy D. Gascoyne, Joseph M. Connors, Richard Klasa, Doug Horsman, David G. Huntsman, Judy Sutherland, Karamjit Gill, Laurie H. Sehn, Séamus O’Reilly and Jane Donaldson and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Nicol Macpherson

25 papers receiving 2.4k citations

Hit Papers

Introduction of Combined CHOP Plus Rituximab Therapy Dram... 2002 2026 2010 2018 2005 2002 200 400 600

Peers

Nicol Macpherson
KA MacLennan United Kingdom
Daniel A. Nikcevich United States
Heike Horn Germany
Dahish Ajarim Saudi Arabia
Scott Cruickshank United States
In‐Gu Do South Korea
KA MacLennan United Kingdom
Nicol Macpherson
Citations per year, relative to Nicol Macpherson Nicol Macpherson (= 1×) peers KA MacLennan

Countries citing papers authored by Nicol Macpherson

Since Specialization
Citations

This map shows the geographic impact of Nicol Macpherson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicol Macpherson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicol Macpherson more than expected).

Fields of papers citing papers by Nicol Macpherson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicol Macpherson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicol Macpherson. The network helps show where Nicol Macpherson may publish in the future.

Co-authorship network of co-authors of Nicol Macpherson

This figure shows the co-authorship network connecting the top 25 collaborators of Nicol Macpherson. A scholar is included among the top collaborators of Nicol Macpherson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicol Macpherson. Nicol Macpherson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Rachel A., et al.. (2024). The Clinical Impact of Time-restricted Eating on Cancer: A Systematic Review. Nutrition Reviews. 83(7). e1660–e1676. 3 indexed citations
2.
Lum, Julian J., et al.. (2022). Intermittent Fasting in Cancer: a Role in Survivorship?. Current Nutrition Reports. 11(3). 500–507. 1 indexed citations
3.
Long, Mengping, Wenjin Shi, Yanru An, et al.. (2019). A novel histone H4 variant H4G regulates rDNA transcription in breast cancer. Nucleic Acids Research. 47(16). 8399–8409. 58 indexed citations
4.
Nielsen, Julie S., Aniqa Shahid, Zusheng Zong, et al.. (2015). Toward Personalized Lymphoma Immunotherapy: Identification of Common Driver Mutations Recognized by Patient CD8+ T Cells. Clinical Cancer Research. 22(9). 2226–2236. 18 indexed citations
5.
West, Nathaniel R., Katy Milne, Pauline T. Truong, et al.. (2011). Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer. Breast Cancer Research. 13(6). R126–R126. 284 indexed citations
6.
Macpherson, Nicol, Andrew R. Belch, Marianne Taylor, et al.. (2006). Liposomal encapsulated doxorubicin (Caelyx) in the treatment of relapsed aggressive non-Hodgkin's lymphoma: A phase II study. Leukemia & lymphoma. 47(7). 1327–1332. 6 indexed citations
7.
Prentice, Leah, Ashleen Shadeo, Valia S. Lestou, et al.. (2005). NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis. Oncogene. 24(49). 7281–7289. 52 indexed citations
8.
Sehn, Laurie H., Jane Donaldson, Mukesh Chhanabhai, et al.. (2005). Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia. Journal of Clinical Oncology. 23(22). 5027–5033. 744 indexed citations breakdown →
9.
Macpherson, Nicol, et al.. (2005). Gene expression changes during acquired resistance to tamoxifen and letrozole; a preclinical model of post-menopausal breast cancer. Journal of Clinical Oncology. 23(16_suppl). 9620–9620. 1 indexed citations
10.
Long, Brian J., Danijela Jelovac, Venkatesh Handratta, et al.. (2004). Therapeutic Strategies Using the Aromatase Inhibitor Letrozole and Tamoxifen in a Breast Cancer Model. JNCI Journal of the National Cancer Institute. 96(6). 456–465. 102 indexed citations
11.
Tognon, Cristina E., Stevan R. Knezevich, David G. Huntsman, et al.. (2002). Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2(5). 367–376. 672 indexed citations breakdown →
12.
Lesperance, Mary, Ivo A. Olivotto, Natalie J. Forde, et al.. (2002). Mega-Dose Vitamins and Minerals in the Treatment of Non-Metastatic Breast Cancer: An Historical Cohort Study. Breast Cancer Research and Treatment. 76(2). 137–143. 74 indexed citations
13.
Gascoyne, Randy D., Nicol Macpherson, Bin Yang, et al.. (2002). Primary Cutaneous Diffuse Large B-Cell Lymphoma. American Journal of Clinical Pathology. 117(4). 574–580. 47 indexed citations
14.
Macpherson, Nicol, Richard Klasa, Randy D. Gascoyne, et al.. (2002). Treatment of Elderly Hodgkin's Lymphoma Patients with a Novel 5-drug Regimen (ODBEP): A Phase II Study. Leukemia & lymphoma. 43(7). 1395–1402. 26 indexed citations
15.
Brodie, A., Qing Lü, Brian J. Long, et al.. (2001). Aromatase and COX-2 expression in human breast cancers. The Journal of Steroid Biochemistry and Molecular Biology. 79(1-5). 41–47. 118 indexed citations
16.
Skinnider, Brian, Philip B. Clement, Nicol Macpherson, Randy D. Gascoyne, & David S. Viswanatha. (1999). Primary non-Hodgkin's lymphoma and malakoplakia of the vagina: A case report. Human Pathology. 30(7). 871–874. 12 indexed citations
17.
Macpherson, Nicol, Richard Klasa, Doug Horsman, et al.. (1999). Small Noncleaved, Non-Burkitt's (Burkitt-Like) Lymphoma: Cytogenetics Predict Outcome and Reflect Clinical Presentation. Journal of Clinical Oncology. 17(5). 1558–1558. 138 indexed citations
18.
O’Reilly, Susan E., Joseph M. Connors, Nicol Macpherson, Richard Klasa, & Paul Hoskins. (1997). Malignant Lymphomas in the Elderly. Clinics in Geriatric Medicine. 13(2). 251–263. 23 indexed citations
19.
Macpherson, Nicol, et al.. (1991). Aminoaciduria as a marker of acute renal transplant rejection--a patient study.. PubMed. 14(2). 111–9. 2 indexed citations
20.
Macpherson, Nicol, et al.. (1987). Protein kinase C activity in renal cortical slices incubated with gentamicin and cyclosporin. Clinical Biochemistry. 20(4). 302–302. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026